MENU
UTHR
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
United Therapeutics (UTHR) Ownership - Who owns United Therapeutics?
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs... Show more
Industry: #Pharmaceuticals Other
Profile
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com
Details
Group
Domestic Stock Funds
Category
Pharmaceuticals
Capitalization
12.6B
P/E Ratio
11.38
Total Cash
3.27B
Projected Growth
0.73
Total Debt
300M
Revenue
2.88B
Risk (Beta)
0.58
Dividend Yield
N/A
Total Cash/Share
72.74
Total Debt/Equity
21.97
Revenue/Share
59.33 USD as % of share price
Fundamentals
UTHR
Capitalization
12.6B
P/E Ratio
11.38
Risk (Beta)
0.58
Dividend Yield
N/A
Total Cash
3.27B
Total Cash/Share
72.74
Total Debt
300M
Total Debt/Equity
21.97
Projected Growth (PEG Ratio)
0.73
Revenue/Share (as % of the share price)
59.33%
Revenue
2.88B
ROE
N/A
Book Value
6.44B
P/B Ratio
1.95
Cash Flow
N/A
Earnings
26.44
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
800K
Current Ratio
5.25
Current Revenue Per Employee
563908.06
Dividends Per Share - Security
N/A
EBITDA
1.65B
Float
N/A
Float - Current
N/A
Gross Income Margin
89.69
Revenue To Assets
16.45
Shares Held By Institutions
37.9B
Shares Outstanding - Current
44.9M
Total Liabilities
920M
Total Volume MTD
N/A
Value
-1
Gain YTD
-20.732
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
1000 Spring Street
Phone
+1 301 608-9292
Employees
1168
Web
https://www.unither.com